Related references
Note: Only part of the references are listed.Immunotherapy for prostate cancer: recent developments and future challenges
Michael T. Schweizer et al.
CANCER AND METASTASIS REVIEWS (2014)
SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7
Shirley Wang et al.
EXPERIMENTAL DERMATOLOGY (2014)
Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndrome
Laetitia Furio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Characterization of Spink6 in Mouse Skin: The Conserved Inhibitor of Kallikrein-Related Peptidases Is Reduced by Barrier Injury
Jan Fischer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
MEROPS: the database of proteolytic enzymes, their substrates and inhibitors
Neil D. Rawlings et al.
NUCLEIC ACIDS RESEARCH (2014)
Proteolytic Activity of Prostate-Specific Antigen (PSA) towards Protein Substrates and Effect of Peptides Stimulating PSA Activity
Johanna M. Mattsson et al.
PLOS ONE (2014)
1,2,4-Triazole derivatives as transient inactivators of kallikreins involved in skin diseases
Xiao Tan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Potential Predictive Biomarkers for Individualizing Treatment for Men With Castration-Resistant Prostate Cancer
Rhonda L. Bitting et al.
CANCER JOURNAL (2013)
Netherton syndrome: skin inflammation and allergy by loss of protease inhibition
Alain Hovnanian
CELL AND TISSUE RESEARCH (2013)
Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease
Azza Eissa et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)
Identification by in silico and in vitro screenings of small organic molecules acting as reversible inhibitors of kallikreins
Xiao Tan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
KLK1 A1789G gene polymorphism and the risk of coronary artery stenosis in the Chinese population
Q. D. Li et al.
GENETICS AND MOLECULAR RESEARCH (2013)
Synthesis and Biological Activity of N-Sulfonyltripeptides with C-Terminal Arginine as Potential Serine Proteases Inhibitors
Agnieszka Markowska et al.
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2013)
Novel KLK4 and MMP20 Mutations Discovered by Whole-exome Sequencing
S. -K. Wang et al.
JOURNAL OF DENTAL RESEARCH (2013)
Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel
Alvin B. Coda et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Lentivirus Mediated Delivery of Neurosin Promotes Clearance of Wild-type α-Synuclein and Reduces the Pathology in an α-Synuclein Model of LBD
Brian Spencer et al.
MOLECULAR THERAPY (2013)
IN VIVO ANALYSIS OF KALLIKREIN-RELATED PEPTIDASE 6 (KLK6) FUNCTION IN OLIGODENDROCYTE DEVELOPMENT AND THE EXPRESSION OF MYELIN PROTEINS
K. Murakami et al.
NEUROSCIENCE (2013)
TGF-β Regulates Enamel Mineralization and Maturation through KLK4 Expression
Andrew Cho et al.
PLOS ONE (2013)
Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer
Yang Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Plasma kallikrein: the bradykinin-producing enzyme
Jenny Bjorkqvist et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Structure of plasma and tissue kallikreins
Monika Pathak et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Immunotherapy and Immune Evasion in Prostate Cancer
Archana Thakur et al.
Cancers (2013)
Coupling of epithelial Na+ and Cl- channels by direct and indirect activation by serine proteases
Veronika Gondzik et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
Non-combinatorial library screening reveals subsite cooperativity and identifies new high-efficiency substrates for kallikrein-related peptidase 14
Simon J. de Veer et al.
BIOLOGICAL CHEMISTRY (2012)
Kallikrein 6 is a novel molecular trigger of reactive astrogliosis
Isobel A. Scarisbrick et al.
BIOLOGICAL CHEMISTRY (2012)
Isomannide derivatives as new class of inhibitors for human kallikrein 7
Renato F. Freitas et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Human kallikrein 6 inhibitors with a para-amidobenzylanmine P1 group identified through virtual screening
Guyan Liang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Transcriptome classification reveals molecular subtypes in psoriasis
Chrysanthi Ainali et al.
BMC GENOMICS (2012)
Kallikrein 6 Regulates Early CNS Demyelination in a Viral Model of Multiple Sclerosis
Isobel A. Scarisbrick et al.
BRAIN PATHOLOGY (2012)
The Role of Sipuleucel-T in Therapy for Castration-Resistant Prostate Cancer: A Critical Analysis of the Literature
Guru Sonpavde et al.
EUROPEAN UROLOGY (2012)
The emergence of factor Xa inhibitors for the treatment of cardiovascular diseases: a patent review
Donald J. P. Pinto et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis
Paola Fortugno et al.
HUMAN MOLECULAR GENETICS (2012)
Doxycycline Indirectly Inhibits Proteolytic Activation of Tryptic Kallikrein-Related Peptidases and Activation of Cathelicidin
Kimberly N. Kanada et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Kallikrein-Related Peptidase 8-Dependent Skin Wound Healing Is Associated with Upregulation of Kallikrein-Related Peptidase 6 and PAR2
Mari Kishibe et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Processing of Neuregulin-1 by Neuropsin Regulates GABAergic Neuron to Control Neural Plasticity of the Mouse Hippocampus
Hideki Tamura et al.
JOURNAL OF NEUROSCIENCE (2012)
Genetic Association of the KLK4 Locus with Risk of Prostate Cancer
Felicity Lose et al.
PLOS ONE (2012)
Targeting the kallikrein-related peptidases for drug development
Georgia Sotiropoulou et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Tissue kallikrein activation of the epithelial Na channel
Ankit B. Patel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Biological evaluation and docking studies of natural isocoumarins as inhibitors for human kallikrein 5 and 7
Thiago S. P. Teixeira et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Prostate Cancer Immunotherapy
Kenneth F. May et al.
CLINICAL CANCER RESEARCH (2011)
Relationships between protein and mineral during enamel development in normal and genetically altered mice
Charles E. Smith et al.
EUROPEAN JOURNAL OF ORAL SCIENCES (2011)
Sipuleucel-T: harbinger of a new age of therapeutics for prostate cancer
Ravi A. Madan et al.
EXPERT REVIEW OF VACCINES (2011)
Therapeutic cancer vaccine fulfills the promise of immunotherapy in prostate cancer
Ravi A. Madan et al.
IMMUNOTHERAPY (2011)
Kallikrein-related Peptidase-8 (KLK8) Is an Active Serine Protease in Human Epidermis and Sweat and Is Involved in a Skin Barrier Proteolytic Cascade
Azza Eissa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Immunotherapy for Prostate Cancer: Biology and Therapeutic Approaches
Edward Cha et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The 3′-UTR AACCins5874 in the stratum corneum chymotryptic enzyme gene (SCCE/KLK7), associated with atopic dermatitis; causes an increased mRNA expression without altering its stability
Yiannis Vasilopoulos et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2011)
The C-Terminal Sequence of Several Human Serine Proteases Encodes Host Defense Functions
Gopinath Kasetty et al.
JOURNAL OF INNATE IMMUNITY (2011)
Inhibition of Transcription Factor Specificity Protein 1 Alters the Gene Expression Profile of Keratinocytes Leading to Upregulation of Kallikrein-Related Peptidases and Thymic Stromal Lymphopoietin
Lianghua Bin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
When Activity Requires Breaking Up: LEKTI Proteolytic Activation Cascade for Specific Proteinase Inhibition
Laetitia Furio et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
TLR2 Expression Is Increased in Rosacea and Stimulates Enhanced Serine Protease Production by Keratinocytes
Kenshi Yamasaki et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Epidermal Proteases in the Pathogenesis of Rosacea
Ulf Meyer-Hoffert et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2011)
Rosacea as a Disease of Cathelicidins and Skin Innate Immunity
Kenshi Yamasaki et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2011)
Neuropsin cleaves EphB2 in the amygdala to control anxiety
Benjamin K. Attwood et al.
NATURE (2011)
Characterization of the prime and non-prime active site specificities of proteases by proteome-derived peptide libraries and tandem mass spectrometry
Oliver Schilling et al.
NATURE PROTOCOLS (2011)
Immunotherapy for the treatment of prostate cancer
Giuseppe Di Lorenzo et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Skin Barrier Homeostasis in Atopic Dermatitis: Feedback Regulation of Kallikrein Activity
Reiko J. Tanaka et al.
PLOS ONE (2011)
Mastering the Canonical Loop of Serine Protease Inhibitors: Enhancing Potency by Optimising the Internal Hydrogen Bond Network
Joakim E. Swedberg et al.
PLOS ONE (2011)
Kallikrein-Related Peptidase 4 Gene (KLK4) in Prostate Tumors: Quantitative Expression Analysis and Evaluation of Its Clinical Significance
Margaritis Avgeris et al.
PROSTATE (2011)
Increased mass levels of certain serine proteases in the stratum corneum in acute eczematous atopic skin
R. Voegeli et al.
INTERNATIONAL JOURNAL OF COSMETIC SCIENCE (2011)
Kallikrein-Related Peptidase 4 A New Activator of the Aberrantly Expressed Protease-Activated Receptor 1 in Colon Cancer Cells
Valerie Gratio et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
Peter Goettig et al.
BIOCHIMIE (2010)
Potential role of multiple members of the kallikrein-related peptidase family of serine proteases in activating latent TGF beta 1 in semen
Nashmil Emami et al.
BIOLOGICAL CHEMISTRY (2010)
Analyzing the protease web in skin: meprin metalloproteases are activated specifically by KLK4, 5 and 8 vice versa leading to processing of proKLK7 thereby triggering its activation
Anke Ohler et al.
BIOLOGICAL CHEMISTRY (2010)
Interdependence of kallikrein-related peptidases in proteolytic networks
Nathalie Beaufort et al.
BIOLOGICAL CHEMISTRY (2010)
Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer
Lina Seiz et al.
BIOLOGICAL CHEMISTRY (2010)
Klk8, a multifunctional protease in the brain and skin: analysis of knockout mice
Shigetaka Yoshida
BIOLOGICAL CHEMISTRY (2010)
Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia
Joakim E. Swedberg et al.
BIOLOGICAL CHEMISTRY (2010)
Kallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation
Georgia Sotiropoulou et al.
BIOLOGICAL CHEMISTRY (2010)
Synthesis of the Proteinase Inhibitor LEKTI Domain 6 by the Fragment Condensation Method and Regioselective Disulfide Bond Formation
Zoe Vasileiou et al.
BIOPOLYMERS (2010)
Molecular mechanism of kallikrein-related peptidase 8/neuropsin-induced hyperkeratosis in inflamed skin
K. Shingaki et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
The Current and Emerging Role of Immunotherapy in Prostate Cancer
Ravi A. Madan et al.
CLINICAL GENITOURINARY CANCER (2010)
Synthetic therapeutic peptides: science and market
Patrick Vlieghe et al.
DRUG DISCOVERY TODAY (2010)
Kallikrein-related peptidase-4 initiates tumor-stroma interactions in prostate cancer through protease-activated receptor-1
Wenbin Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Philip W. Kantoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Par2 Inactivation Inhibits Early Production of TSLP, but Not Cutaneous Inflammation, in Netherton Syndrome Adult Mouse Model
Anais Briot et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Kallikrein Expression and Cathelicidin Processing Are Independently Controlled in Keratinocytes by Calcium, Vitamin D3, and Retinoic Acid
Shin Morizane et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products
Oded Kleifeld et al.
NATURE BIOTECHNOLOGY (2010)
Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome
Katiuchia Uzzun Sales et al.
NATURE GENETICS (2010)
Emerging principles in protease-based drug discovery
Marcin Drag et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Ecallantide
Bruce Zuraw et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Extracellular neurosin degrades α-synuclein in cultured cells
Harutsugu Tatebe et al.
NEUROSCIENCE RESEARCH (2010)
Ecallantide for the Treatment of Acute Attacks in Hereditary Angioedema
Marco Cicardi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Tissue kallikrein permits early renal adaptation to potassium load
Soumaya El Moghrabi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Crystal structure of recombinant human tissue kallikrein at 2.0 Å resolution
Bradley A. Katz et al.
PROTEIN SCIENCE (2010)
Activity-based protein profiling for biochemical pathway discovery in cancer
Daniel K. Nomura et al.
NATURE REVIEWS CANCER (2010)
Specific inhibition of tissue kallikrein 1 with a human monoclonal antibody reveals a potential role in airway diseases
Daniel J. Sexton et al.
BIOCHEMICAL JOURNAL (2009)
A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15
Hyesook Yoon et al.
BIOLOGICAL CHEMISTRY (2009)
Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancer
Aaron M. LeBeau et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer
Ravi A. Madan et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Promising novel immunotherapies and combinations for prostate cancer
Philip M. Arlen et al.
FUTURE ONCOLOGY (2009)
The lupus-susceptibility gene kallikrein downmodulates antibody-mediated glomerulonephritis
Q-Z Li et al.
GENES AND IMMUNITY (2009)
Hypomaturation Enamel Defects in Klk4 Knockout/LacZ Knockin Mice
James P. Simmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Kallikreins and lupus nephritis
Claudio Ponticelli et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome
Anais Briot et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Evidence for a common pathway linking neurodegenerative diseases
Joshua M. Shulman et al.
NATURE GENETICS (2009)
Mechanisms of Disease: Psoriasis.
Frank O. Nestle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Molecular insights into substrate specificity of prostate specific antigen through structural modeling
Pratap Singh et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2009)
Substrate specificity determination of mouse implantation serine proteinase and human kallikrein-related peptidase 6 by phage display
Navneet Sharma et al.
BIOLOGICAL CHEMISTRY (2008)
Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7
Mekdes Debela et al.
BIOLOGICAL CHEMISTRY (2008)
Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions
Azza Eissa et al.
BIOLOGICAL CHEMISTRY (2008)
Serine peptidases: Classification, structure and function
M. J. Page et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Kallikrein-related peptidases
A. Lundwall et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Potent and selective peptidyl boronic acid inhibitors of the serine protease Prostate-Specific Antigen
Aaron M. LeBeau et al.
CHEMISTRY & BIOLOGY (2008)
Tissue kallikrein deficiency aggravates cardiac remodelling and decreases survival after myocardial infarction in mice
Sandrine Pons et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Experimental Rhinovirus Infection Increases Human Tissue Kallikrein Activation in Allergic Subjects
Sandra C. Christiansen et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2008)
Participation of kallikrein-kinin system in different pathologies
Claudio M. Costa-Neto et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Major role of human KLK14 in seminal clot liquefaction
Nashmil Emami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs)
Andrew J. Ramsay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases
Kristina Stefansson et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Protease proteomics: Revealing protease in vivo functions using systems biology approaches
Alain Doucet et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Prostate-specific kallikreins-2 and-4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and-2
Gregory J. Mize et al.
MOLECULAR CANCER RESEARCH (2008)
Neuregulin 1 in neural development, synaptic plasticity and schizophrenia
Lin Mei et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Genetic Variations of Human Neuropsin Gene and Psychiatric Disorders: Polymorphism Screening and Possible Association with Bipolar Disorder and Cognitive Functions
Aiko Izumi et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Cleavage of normal and pathological forms of α-synuclein by neurosin in vitro
Takashi Kasai et al.
NEUROSCIENCE LETTERS (2008)
Novel small molecule inhibitors for prostate-specific antigen
Hannu Koistinen et al.
PROSTATE (2008)
Substrate specificity of human kallikreins 1 and 6 determined by phage display
Hai-Xin Li et al.
PROTEIN SCIENCE (2008)
Defective ENaC processing and function in tissue kallikrein-deficient mice
Nicolas Picard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade - Possible function in seminal plasma and skin
Nashmil Emami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
Hans Lilja et al.
NATURE REVIEWS CANCER (2008)
New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family
Nashmil Emami et al.
MOLECULAR ONCOLOGY (2007)
Structural basis of the zinc inhibition of human tissue kallikrein 5
Mekdes Debela et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Activation profiles and regulatory cascades of the human kallikrein-related peptidases
Hyesook Yoon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Defining the extended substrate specificity of kallikrein 1-related peptidases
Carla A. Borgono et al.
BIOLOGICAL CHEMISTRY (2007)
Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa
Donald J. P. Pinto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Chymotryptic specificity determinants in the 1.0 Å structure of the zinc-inhibited human tissue kallikrein 7
Mekdes Debela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control I desquamation through a pH-dependent interaction
Celine Deraison et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Neuropsin promotes oligodendrocyte death, demyelination and axonal degeneration after spinal cord injury
R. Terayama et al.
NEUROSCIENCE (2007)
Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea
Kenshi Yamasaki et al.
NATURE MEDICINE (2007)
Distribution of 15 human kallikreins in tissues and biological fluids
Julie L. V. Shaw et al.
CLINICAL CHEMISTRY (2007)
Expression and enzymatic characterization of recombinant human kallikrein 14
Sanath Rajapakse et al.
ZOOLOGICAL SCIENCE (2007)
Regulation of the epithelial calcium channel TRPV5 by extracellular factors
Catalin N. Topala et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2007)
Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients
Nahoko Komatsu et al.
EXPERIMENTAL DERMATOLOGY (2007)
Activity and stability of human kalikrein-2-specific linear and cyclic peptide inhibitors
Miikka Pakkala et al.
JOURNAL OF PEPTIDE SCIENCE (2007)
Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy
N. Komatsu et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Enzymatic properties of human kallikrein-related peptidase 12 (KLK12)
Nader Memari et al.
BIOLOGICAL CHEMISTRY (2007)
Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer
Jin Gao et al.
PROSTATE (2007)
Kallikrein 8 is involved in skin desquamation in cooperation with other kallikreins
Mari Kishibe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation
Carla A. Borgono et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Seminal fluid characterization for male fertility and prostate cancer: Kallikrein-related serine proteases and whole proteome approaches
Tara L. Veveris-Lowe et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
Mechanisms of disease: The tissue kallikrein-kinin system in hypertension and vascular remodeling
Paolo Madeddu et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2007)
Crystal structures of human tissue kallikrein 4: Activity modulation by a specific zinc binding site
Mekdes Debela et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Implications of protease M/neurosin in myelination during experimental demyelination and remyelination
Yoshio Bando et al.
NEUROSCIENCE LETTERS (2006)
Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences
Mekdes Debela et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome
Jean-Pierre Hachem et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum
Kristina Stefansson et al.
BIOLOGICAL CHEMISTRY (2006)
Mutant recombinant serpins as highly specific inhibitors of human kallikrein 14
Loyse M. Felber et al.
FEBS JOURNAL (2006)
Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression
IP Michael et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Epidermal growth factor receptor activation by epidermal growth factor mediates oxidant-induced goblet cell metaplasia in human airway epithelium
SM Casalino-Matsuda et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
Role of neuropsin in formation and maturation of Schaffer-collateral L1cam-immunoreactive synaptic boutons
Y Nakamura et al.
JOURNAL OF CELL SCIENCE (2006)
Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
F Noorbakhsh et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Neuropsin is essential for early processes of memory acquisition and Schaffer collateral long-term potentiation in adult mouse hippocampus in vivo
H Tamura et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
AP-2α:: a regulator of EGF receptor signaling and proliferation in skin epidermis
X Wang et al.
JOURNAL OF CELL BIOLOGY (2006)
Targeting proteases: successes, failures and future prospects
Boris Turk
NATURE REVIEWS DRUG DISCOVERY (2006)
Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins
S Rajapakse et al.
FEBS LETTERS (2005)
Quantification of human tissue kallikreins in the stratum corneum: Dependence on age and gender
N Komatsu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Involvement of neuropsin in the pathogenesis of experimental autoimmune encephalomyelitis
R Terayama et al.
GLIA (2005)
The catalytic triad of serine peptidases
L Polgar
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells
TL Veveris-Lowe et al.
ENDOCRINE-RELATED CANCER (2005)
Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity
JP Hachem et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases
N Komatsu et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Transcriptional profiling of keratinocytes reveals a vitamin D-regulated epidermal differentiation network
JF Lu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
1.70 Å X-ray structure of human apo kallikrein 1:: Structural changes upon peptide inhibitor/substrate binding
G Laxmikanthan et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
Enzymatic profiling of human kallikrein 14 using phage-display substrate technology
LM Felber et al.
BIOLOGICAL CHEMISTRY (2005)
LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum
A Ishida-Yamamoto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries
M Matsumura et al.
PROSTATE (2005)
Osteoblasts in prostate cancer metastasis to bone
CJ Logothetis et al.
NATURE REVIEWS CANCER (2005)
Psoriasis: Emerging therapeutic strategies
AB Gottlieb
NATURE REVIEWS DRUG DISCOVERY (2005)
The kallikrein-kinin system: Current and future pharmacological targets
ME Moreau et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
A proteolytic cascade of kallikreins in the stratum corneum
M Brattsand et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Leukocytic cell sources of airway tissue kallikrein
IT Lauredo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates
SM Cloutier et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Mutation in kallikrein 4 causes autosomal recessive hypomaturation amelogenesis imperfecta
PS Hart et al.
JOURNAL OF MEDICAL GENETICS (2004)
The emerging roles of human tissue kallikreins in cancer
CA Borgoño et al.
NATURE REVIEWS CANCER (2004)
Differential expression of neuropsin and protease M/neurosin in oligodendrocytes after injury to the spinal cord
R Terayama et al.
GLIA (2004)
Human kallikrein 13 involvement in extracellular matrix degradation
C Kapadia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve
LC Costello et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2004)
Role of hyaluronan and reactive oxygen species in tissue kallikrein-mediated epidermal growth factor receptor activation in human airways
SM Casalino-Matsuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Bradykinin receptor ligands: Therapeutic perspectives
F Marceau et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies
A Iwata et al.
HUMAN MOLECULAR GENETICS (2003)
LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome
E Bitoun et al.
HUMAN MOLECULAR GENETICS (2003)
Prolonged recovery of ultraviolet B-irradiated skin in neuropsin (KLK8)-deficient mice
T Kirihara et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Elevated tissue kallikrein activity in airway secretions from patients with tracheobronchitis associated with prolonged mechanical ventilation
TG O' Riordan et al.
LUNG (2003)
Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors
A Magklara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Role of kallikrein enzymes in the central nervous system
GM Yousef et al.
CLINICA CHIMICA ACTA (2003)
Strategies for MMP inhibition in cancer:: Innovations for the post-trial era
CM Overall et al.
NATURE REVIEWS CANCER (2002)
Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system
MJ Bernett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology
SM Cloutier et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients
M Zarghooni et al.
CLINICAL BIOCHEMISTRY (2002)
Design of new and sensitive fluorogenic substrates for human kallikrein hK3 (prostate-specific antigen) derived from semenogelin sequences
S Réhault et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2002)
Enzymatic properties of rat myelencephalon-specific protease
SI Blaber et al.
BIOCHEMISTRY (2002)
Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides
N Komatsu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Modulation of recombinant human prostate-specific antigen: Activation by Hofmeister salts and inhibition by azapeptides
XY Huang et al.
BIOCHEMISTRY (2001)
Hyaluronan serves a novel role in airway mucosal host defense
R Forteza et al.
FASEB JOURNAL (2001)
Strategies for the inhibition of serine proteases
B Walker et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice
P Meneton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4
GM Yousef et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease
K Ogawa et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2000)
Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome
S Chavanas et al.
NATURE GENETICS (2000)
Neuropsin regulates an early phase of Schaffer-collateral long-term potentiation in the murine hippocampus
S Komai et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Share Paper
